Do Endotypes Predict Response and Sequelae in OSA Patients
University of California, San Diego
200 participants
Aug 1, 2020
INTERVENTIONAL
Conditions
Summary
This study will investigate why some people have Obstructive Sleep Apnea (OSA) and how the underlying cause may relate to OSA manifestations (including sleepiness and high blood pressure) and response to different therapeutic approaches (ie CPAP, eszopiclone, and supplemental oxygen). Understanding why someone has OSA could affect how best to treat that individual, but may also have an impact on what problems the disease might cause.
Eligibility
Plain Language Summary
Simplified for easier understanding
This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
2mg of Eszopiclone just before going to sleep.
Constant oxygen flow at 4 Liters per minutes for the duration of time in bed via nasal cannula.
A standard CPAP device will be provided using the settings as prescribed by the treating physician.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT04875364